Peripheral neuropathy decisions — 2026

The Veteran's right and left upper extremity peripheral neuropathy disabilities are granted with ratings of 40% and 30%, respectively, effective February 4, 2019.,Effective February 4, 2019, the Veteran is granted eligibility for Dependents' Educational Assistance (DEA) under 38 U.S.C. chapter 35.

The Veteran's right and left lower extremity axonal polyneuropathy were rated at 10 percent prior to January 31, 2025. The Board denied a higher rating as the evidence did not show moderate or severe incomplete paralysis.

The Board has granted service connection for the Veteran's lumbar spine disability, left lower extremity peripheral neuropathy, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and right upper extremity peripheral neuropathy due to presumed exposure to herbicide agents during his service in the Republic of Vietnam.

The Board has granted service connection for the Veteran's bilateral lower and upper extremity neuropathies, finding that they are related to his in-service herbicide exposure (Agent Orange).

The Board has remanded the claims for service connection for left toe amputation, triple bypass surgery, blockage in legs, and bilateral tinnitus due to procedural errors and the need for additional medical opinions regarding potential exposure to toxins during service.

The Veteran's appeals for increased evaluations and service connection were dismissed due to his death.

The Veteran's service-connected disabilities rendered him so helpless as to be in need of regular aid and attendance, leading to the grant of SMC based on aid and attendance.

The Veteran's appeal was dismissed due to their death during the pendency of the appeal.

The Veteran's claim for service connection for an elbow disorder manifested by pain, and reduced elbow, wrist, and grip strength is being remanded due to a duty to assist error. The Board requests additional clarification on whether the Veteran has a current elbow disability and requires an adequate medical opinion.

The Veteran's claims for service connection were denied, and the Board found that an earlier effective date was not warranted. The issues of increased disability ratings for residuals of a pilonidal cyst on the tailbone, DMII, and diabetic peripheral neuropathy of the bilateral lower extremities are remanded.

The Board has granted service connection for chronic lymphocytic leukemia, diabetes mellitus type II, and bilateral lower extremity neuropathy. The Veteran's cause of death due to these conditions is also recognized.

The Board has determined that the Veteran does not have any of the claimed conditions and there is no evidence linking them to his service. The claims for depression, insomnia, sleep apnea, skeletal arthritis, chronic pain, muscle spasm, left upper extremity neuropathy and nerve pain, right upper extremity neuropathy and nerve pain, left lower extremity neuropathy and nerve pain, and right lower extremity neuropathy and nerve pain are all denied.

The Board has granted service connection for bilateral upper and lower extremity peripheral neuropathy, finding that the Veteran's condition is due to his exposure to herbicide agents during service.

The Board has remanded the claims for asthma, hypertension with residuals including stroke, DM II, bilateral amputation of all toes, and diabetic neuropathy to obtain VA medical opinions regarding the nature and etiology of these conditions.,The Board also remanded the claim for ED as it is inextricably intertwined with the DM II claim.

The Veteran's appeal for service connection for Marfan's syndrome was dismissed as the appellant withdrew his request.,Service connection is granted for left lower extremity neuropathy of the sciatic nerve (left foot disability) and peripheral neuropathy of the right lower extremity. The low back degenerative arthritis has also been granted.

The Board has granted the Veteran's requests to readjudicate his claims for service connection for coronary atherosclerosis and diabetes mellitus type II, but has remanded the cases due to new evidence received. The claims are being remanded for toxic exposure risk activity (TERA) medical opinions regarding any possible nexus between the Veteran's claimed exposures in Camp Lejeune and his conditions.

The Veteran's Special Monthly Compensation (SMC) based on the need for regular Aid and Attendance is granted as of April 25, 2024.,For diabetes mellitus, a rating in excess of 20 percent is denied.

The Veteran withdrew his appeals for service connection of peripheral neuropathy in all four extremities, resulting in the dismissal of these claims.

The Veteran's appeal was granted for various disabilities, including service connection for depressive disorder and increased evaluations for diabetic peripheral neuropathy affecting multiple nerve groups. A SMC based on need for aid and attendance was also awarded.

The Veteran withdrew his appeals for service connection of peripheral neuropathy in all four extremities, resulting in the dismissal of these claims.